Science

Mar 10, 2025, 09:12

Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy, and ANXA1 inhibition may effectively diminish BCMA-negative myeloma.”

“Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMAnegative relapse after CAR-T therapy”

Authors: Shuangshuang Yang, Guixiang Wang, Jiahuan Chen, Wu Zhang, Jing Wu, Weiqing, Liu, Ling Bai, Peide Huang, Jianqing Mi, Jie Xu.

More posts featuring Robert Orlowski.

BCMA-negative myeloma cancer CAR-T therapy Guixiang Wang Jiahuan Chen Jianqing Mi Jie Xu Jing Wu Ling Bai LIU Myeloma Paper of the Day OncoDaily Oncology Peide Huang Robert Orlowski Shuangshuang Yang Weiqing Wu Zhang

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter